Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11708378 Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
March 19, 2021
0
Date of Patent
July 25, 2023
0
Patent Application Number
17206488
0
Patent Citations
‌
US Patent 8242116 Fused thiazole derivatives as kinase inhibitors
0
‌
US Patent 8338592 Fused thiazole derivatives as kinase inhibitors
0
‌
US Patent 8710054 Fused thiazole derivatives as kinase inhibitors
0
‌
US Patent 8921361 Triazine, pyrimidine and pyridine analogs and their use as therapeutic agents and diagnostic probes
0
‌
US Patent 8981087 Benzo [E] [1,3] oxazin-4-one derivatives as phosphoinositide 3-kinase inhibitors
0
‌
US Patent 9200007 Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors
0
‌
US Patent 9266879 Naphthridine derivatives as PI3K inhibitors for the treatment of cancer and immune-inflammatory disease
0
‌
US Patent 9580442 Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors
0
‌
US Patent 9663487 Phosphoinositide 3-kinase inhibitors
0
‌
US Patent 9868749 Fused imidazole and pyrazole derivatives as modulators of TNF activity
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11708378
0
Patent Primary Examiner
‌
Rebecca L Anderson
0
CPC Code
‌
C07D 519/00
0
‌
C07D 491/14
0

Find more entities like US Patent 11708378 Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo